In vitro transfection mediated by dendrigraft poly(L-lysines): The effect of structure and molecule size

Macromolecular Bioscience

Volumn 13, Issue 2, 2013, Pages 167-176

  Hofman, Jakub ^a,c   Buncek, Martin ^a   Haluza, Radovan ^a   Streinz, Ludvik ^b   Ledvina, Miroslav ^b   Cigler, Petr ^b  

^a GENERI BIOTECH   (Czech Republic)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Dendrigraft poly(L lysines); Dendrimers; Drug delivery systems; Structure property relations; Transfection

Indexed keywords

DENDRIGRAFT POLY(L-LYSINES); DNASE I; DRUG DELIVERY SYSTEM; HEP-2 CELL LINES; HEP-2 CELLS; IN-VITRO; LIPOFECTAMINE; MOLECULE SIZES; NONVIRAL; STRUCTURE PROPERTY RELATION; TRANSFECTION; TRANSFECTION ABILITY;

CELL CULTURE; DENDRIMERS; DRUG DELIVERY; LIPOSOMES; MOLECULES; OLIGONUCLEOTIDES;

AMINO ACIDS;

ANTISENSE OLIGONUCLEOTIDE; COPOLYMER; DENDRIMER; DEOXYRIBONUCLEASE I; LIPOFECTAMINE; LYSINE; OLIGONUCLEOTIDE; POLYLYSINE; SMALL INTERFERING RNA;

ANTISENSE THERAPY; ARTICLE; CELL CULTURE; CELL DEATH; CELL MEMBRANE; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; DEGRADATION; DISSOCIATION; DNA HELIX; ENDOCYTOSIS; GENE DELIVERY SYSTEM; GENE THERAPY; HYDROLYSIS; IC 50; IN VITRO GENE TRANSFER; INTERNALIZATION; MOLECULAR SIZE; MOLECULAR WEIGHT; NONVIRAL GENE DELIVERY SYSTEM; NUCLEASE PROTECTION ASSAY; PHYSICAL CHEMISTRY; STRUCTURE ACTIVITY RELATION;

BASE SEQUENCE; CELL LINE; CELL SURVIVAL; DEOXYRIBONUCLEASE I; GREEN FLUORESCENT PROTEINS; HUMANS; LIPIDS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; PLASMIDS; POLYLYSINE; RNA, SMALL INTERFERING; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 84874047382     PISSN: 16165187     EISSN: 16165195     Source Type: Journal    
DOI: 10.1002/mabi.201200303     Document Type: Article

References (42)

1. S. J. Teerstra, M. Gauthier, Prog. Polym. Sci. 2004, 29, 277.
2. I. Tsogas, T. Theodossiou, Z. Sideratou, C. M. Paleos, H. Collet, J. C. Rossi, B. Romestand, A. Commeyras, Biomacromolecules 2007, 8, 3263.
3. H. Collet, E. Souaid, H. Cottet, A. Deratani, L. Boiteau, G. Dessalces, J. C. Rossi, A. Commeyras, R. Pascal, Chem. Eur. J. 2010, 16, 2309.
4. U. Boas, P. M. Heegaard, Chem. Soc. Rev. 2004, 33, 43.
5. Y. Cheng, L. Zhao, Y. Li, T. Xu, Chem. Soc. Rev. 2011, 40, 2673.
6. I. J. Majoros, C. R. Williams, J. R. Baker, Jr., Curr. Top. Med. Chem. 2008, 8, 1165.
7. C. Dufes, I. F. Uchegbu, A. G. Schatzlein, Adv. Drug Delivery Rev. 2005, 57, 2177.
8. C. M. Paleos, L. A. Tziveleka, Z. Sideratou, D. Tsiourvas, Expert Opin. Drug Delivery 2009, 6, 27.
9. W. F. Anderson, Nature 1998, 392, 25.
10. D. S. Anson, Genet. Vaccines Ther. 2004, 2, 9.
11. V. Nair, Curr. Opin. Mol. Ther. 2008, 10, 431.
12. H. Eliyahu, Y. Barenholz, A. J. Domb, Molecules 2005, 10, 34.
13. C. Tros de Ilarduya, Y. Sun, N. Duzgunes, Eur. J. Pharm. Sci. 2010, 40, 159.
14. A. El-Aneed, J. Controlled Release 2004, 94, 1.
15. T. G. Park, J. H. Jeong, S. W. Kim, Adv. Drug Delivery Rev. 2006, 58, 467.
16. H. S. Parekh, Curr. Pharm. Des. 2007, 13, 2837.
17. I. A. Khalil, K. Kogure, H. Akita, H. Harashima, Pharmacol. Rev. 2006, 58, 32.
18. O. Boussif, F. Lezoualc'h, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, J. P. Behr, Proc. Natl. Acad. Sci. USA 1995, 92, 7297.
19. D. Lechardeur, G. L. Lukacs, Curr. Gene Ther. 2002, 2, 183.
20. C. Pichon, L. Billiet, P. Midoux, Curr. Opin. Biotechnol. 2010, 21, 640.
21. M. Ohsaki, T. Okuda, A. Wada, T. Hirayama, T. Niidome, H. Aoyagi, Bioconjug. Chem. 2002, 13, 510.
22. M. Mannisto, S. Vanderkerken, V. Toncheva, M. Elomaa, M. Ruponen, E. Schacht, A. Urtti, J. Controlled Release 2002, 83, 169.
23. T. Okuda, A. Sugiyama, T. Niidome, H. Aoyagi, Biomaterials 2004, 25, 537.
24. K. D. Eom, S. M. Park, H. D. Tran, M. S. Kim, R. N. Yu, H. Yoo, Pharm. Res. 2007, 24, 1581.
25. M. Yamagata, T. Kawano, K. Shiba, T. Mori, Y. Katayama, T. Niidome, Bioorg. Med. Chem. 2007, 15, 526.
26. Y. Inoue, R. Kurihara, A. Tsuchida, M. Hasegawa, T. Nagashima, T. Mori, T. Niidome, Y. Katayama, O. Okitsu, J. Controlled Release 2008, 126, 59.
27. K. Watanabe, M. Harada-Shiba, A. Suzuki, R. Gokuden, R. Kurihara, Y. Sugao, T. Mori, Y. Katayama, T. Niidome, Mol. Biosyst. 2009, 5, 1306.
28. K. Luo, C. Li, G. Wang, Y. Nie, B. He, Y. Wu, Z. Gu, J. Controlled Release 2011, 155, 77.
29. Y. Li, Y. Zhu, K. Xia, R. Sheng, L. Jia, X. Hou, Y. Xu, A. Cao, Biomacromolecules 2009, 10, 2284.
30. Y. Zhu, R. Sheng, T. Luo, H. Li, W. Sun, Y. Li, A. Cao, Macromol. Biosci. 2011, 11, 174.
31. S. Pan, C. Wang, X. Zeng, Y. Wen, H. Wu, M. Feng, Int. J. Pharm. 2011, 420, 206.
32. R. Huang, S. Liu, K. Shao, L. Han, W. Ke, Y. Liu, J. Li, S. Huang, C. Jiang, Nanotechnology 2010, 21, 265101.
33. H. Cottet, M. Martin, A. Papillaud, E. Souaid, H. Collet, A. Commeyras, Biomacromolecules 2007, 8, 3235.
34. M. Breunig, U. Lungwitz, R. Liebl, A. Goepferich, Proc. Natl. Acad. Sci. USA 2007, 104, 14454.
35. K. Jain, P. Kesharwani, U. Gupta, N. K. Jain, Int. J. Pharm. 2010, 394, 122.
36. L. E. Prevette, D. G. Mullen, M. M. Holl, Mol. Pharm. 2010, 7, 870.
37. D. Fischer, Y. Li, B. Ahlemeyer, J. Krieglstein, T. Kissel, Biomaterials 2003, 24, 1121.
38. J. Dai, S. Zou, Y. Pei, D. Cheng, H. Ai, X. Shuai, Biomaterials 2011, 32, 1694.
39. A. Harada, M. Kawamura, T. Matsuo, T. Takahashi, K. Kono, Bioconjug. Chem. 2006, 17, 3.
40. M. L. Patil, M. Zhang, T. Minko, ACS Nano 2011, 5, 1877.
41. Y. W. Cho, J. D. Kim, K. Park, J. Pharm. Pharmacol. 2003, 55, 721.
42. P. Midoux, C. Pichon, J. J. Yaouanc, P. A. Jaffres, Br. J. Pharmacol. 2009, 157, 166.